Limba
Romanian
Romanian
English|
Ziftomenib (KO-539) is an oral inhibitor of menintargeting the menin–KMT2Aprotein-protein interaction. It exhibits antileukemic activity and induces apoptosis of acute myeloid leukemia(AML) cells.
| Price | 9.765,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Ziftomenib (KO-539) is an oral inhibitor of menintargeting the menin–KMT2Aprotein-protein interaction. It exhibits antileukemic activity and induces apoptosis of acute myeloid leukemia(AML) cells. |
